Brought to you by 
Series C raises $27.4mm for Spinal Modulation
15 Jun 2011
Executive Summary
Spinal device developer Spinal Modulation raised $27.4mm in its Series C financing led by first-time backer Johnson & Johnson Development Corp., which was joined by other new investors DFJ InCube Ventures and Raffles Venture Partners and returning shareholders De Novo Ventures, DFJ ePlanet Ventures, Kleiner Perkins Caufield & Byers, and MedVenture Associates.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series C raises $27.4mm for Spinal Modulation
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice